Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
S-95024 by Les Laboratoires Servier for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According...
S-95024 by Les Laboratoires Servier for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Esophageal Squamous Cell Carcinoma (ESCC)....
S-95024 by Les Laboratoires Servier for Non-Small Cell Lung Carcinoma: Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Non-Small Cell Lung Carcinoma. According...
S-95024 by Les Laboratoires Servier for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Head And Neck Squamous Cell...
S-95024 by Les Laboratoires Servier for Metastatic Colorectal Cancer: Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Metastatic Colorectal Cancer. According to...
S-95024 by Les Laboratoires Servier for Malignant Pleural Mesothelioma: Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Malignant Pleural Mesothelioma. According to...
S-95024 by Les Laboratoires Servier for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to...
S-95024 by Les Laboratoires Servier for Solid Tumor: Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Solid Tumor. According to GlobalData,...
S-95024 by Les Laboratoires Servier for Gastric Cancer: Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Gastric Cancer. According to GlobalData,...
S-95024 by Les Laboratoires Servier for Cervical Cancer: Likelihood of Approval
S-95024 is under clinical development by Les Laboratoires Servier and currently in Phase II for Cervical Cancer. According to GlobalData,...